We are live on
!
Find out more
JA
JLB & Associates Portfolio holdings
AUM
$696M
1-Year Est. Return
17.86%
This Fund
S&P 500
This Quarter
Est. Return
+1.73%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$219M
AUM Growth
–
Cap. Flow
+$221M
Cap. Flow
% of AUM
100.59%
Top 10 Holdings %
Top 10 Hldgs %
30.09%
Holding
73
New
73
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
McCormick & Company Non-Voting
MKC
|
+$7.94M |
| 2 |
Gilead Sciences
GILD
|
+$7.72M |
| 3 |
Oracle
ORCL
|
+$7.37M |
| 4 |
Accenture
ACN
|
+$6.95M |
| 5 |
Ametek
AME
|
+$6.69M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Healthcare | 17.02% |
| 3 | Consumer Discretionary | 16.96% |
| 4 | Industrials | 13.16% |
| 5 | Consumer Staples | 11.77% |
Similar funds
AAM
CA
CA
FCM
GUB
AWC
BBPWM
SCM
JLB & Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for JLB & Associates, which disclosed 73 positions worth $219M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is McCormick & Company Non-Voting: 220,524 shares worth $7.76M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Healthcare and Consumer Discretionary.
- JLB & Associates's largest Q2 2013 buy was McCormick & Company Non-Voting: 220,524 shares worth $7.76M.
- JLB & Associates's ten largest holdings make up 30% of its $219M portfolio in Q2 2013.
- JLB & Associates disclosed 73 positions in Q2 2013, its first 13F filing on record.
Based on JLB & Associates's 13F filing for Q2 2013, filed 12 Aug 2013.